Perfil
Premal Patel worked as Head-Early Clinical Development at Pfizer Inc. from 2015 to 2017.
He then worked as SVP & Head-Early Clinical Drug Development at Juno Therapeutics, Inc. from 2017 to 2018.
From 2018 to 2020, he served as Chief Medical Officer at Lyell Immunopharma, Inc. In 2021, he worked as Chief Medical Officer at eFFECTOR Therapeutics, Inc. Patel holds a doctorate degree from the University of Washington and an undergraduate degree from Rutgers State University of New Jersey.
Antiguos cargos conocidos de Premal Patel.
| Empresas | Cargo | Fin |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/04/2022 |
| LYELL IMMUNOPHARMA, INC. | Director Técnico/Científico/I+D | 01/04/2020 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/04/2018 |
| PFIZER INC. | Corporate Officer/Principal | 01/08/2017 |
Formación de Premal Patel.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
- Bolsa de valores
- Insiders
- Premal Patel
















